$950.000 Tıbbi Uygulama Hatası Anlaşması
Ağustos 2, 2017
Kategori: Tıbbi Uygulama Hatası
Öne Çıkan Avukatlar
Ortak
Blogumuzdan Makaleler
Andexanet Alfa (Andexxa) Withdrawn from U.S. Market: What Patients Need to Know
by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or...
Makaleyi okuPFAS in Biosolids: 2025 Statehouses Take the Lead
For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...
Makaleyi okuSuspected Birth Injury? What Parents Need to Know and Do Next
Bringing a baby into the world is supposed to be joyful. When something goes wrong during pregnancy, labor, or delivery, that joy can be replaced in an instant...
Makaleyi oku